The latest prostate cancer news
More targeted, less toxic: The golden future of cancer treatment
Researchers have engineered gold-based molecules that target cancer cells and leave healthy cells unharmed, in…
The latest prostate cancer news
Researchers have engineered gold-based molecules that target cancer cells and leave healthy cells unharmed, in…
By Monique Biryiana In 2018, prostate cancer was the second most common cancer in men,…
While we were set a very high benchmark on the back of last year’s ASM,…
A new large population-based study shows that novel oral androgen signalling inhibitor therapies are associated…
Here is ecancer’s speedy recap on the presentations from the 2019 American Society of Clinical…
Some 5,400 men are diagnosed with prostate cancer in Finland every year. Although in most…
The Food and Drug Administration (FDA) approved darolutamide for non-metastatic castration-resistant prostate cancer. Approval of…
Stephen McMahon, Queen’s University Belfast High energy proton beam therapy, an advanced form of radiotherapy,…
More than 174,000 men will be diagnosed with prostate cancer this year, according to the…
Researchers at the University of East Anglia and the Norfolk and Norwich University Hospital have…